GRI
Income statement / Annual
Last year (2024), GRI Bio, Inc.'s total revenue was $22.54 M,
and the percentage change from the previous year is not available.
In 2024, GRI Bio, Inc.'s net income was -$8.21 M.
See GRI Bio, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$22.54 M |
$0.00 |
$0.00 |
$0.00 |
$100.00 K |
$0.00 |
$0.00 |
| Cost of Revenue |
$11.63 M
|
$0.00
|
$0.00
|
$0.00
|
$100.00 K
|
$735.00
|
$612.00
|
| Gross Profit |
$10.91 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$735.00
|
-$612.00
|
| Gross Profit Ratio |
0.48
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$3.77 M
|
$3.23 M
|
$242.00 K
|
$249.00 K
|
$3.71 M
|
$1.88 M
|
$3.51 M
|
| General & Administrative Expenses |
$4.47 M
|
$8.16 M
|
$2.00 M
|
$813.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$4.47 M
|
$8.16 M
|
$2.00 M
|
$813.00 K
|
$1.11 M
|
$1.27 M
|
$800.08 K
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$8.24 M
|
$11.39 M
|
$2.24 M
|
$1.06 M
|
$4.81 M
|
$3.15 M
|
$4.31 M
|
| Cost And Expenses |
$8.24 M
|
$11.39 M
|
$2.24 M
|
$1.06 M
|
-$4.89 M
|
-$3.15 M
|
-$4.31 M
|
| Interest Income |
$25.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.06 K
|
| Interest Expense |
$0.00
|
$2.08 M
|
$653.00 K
|
$547.00 K
|
$34.00 K
|
$197.03 K
|
$0.00
|
| Depreciation & Amortization |
$4.00 K
|
$57.00 K
|
$50.00 K
|
$73.00 K
|
$75.00 K
|
$735.00
|
$612.00
|
| EBITDA |
-$8.23 M |
-$10.90 M |
-$2.51 M |
-$939.00 K |
-$4.71 M |
-$3.27 M |
-$4.31 M |
| EBITDA Ratio |
-0.37
|
0
|
0
|
0
|
-47.13
|
0
|
0
|
| Operating Income Ratio |
-0.37
|
0
|
0
|
0
|
-47.88
|
0
|
0
|
| Total Other Income/Expenses Net |
$28.00 K
|
-$1.65 M
|
-$978.00 K
|
-$497.00 K
|
-$34.00 K
|
-$310.07 K
|
$1.06 K
|
| Income Before Tax |
-$8.21 M
|
-$13.04 M
|
-$3.22 M
|
-$1.56 M
|
-$4.82 M
|
-$3.46 M
|
-$4.31 M
|
| Income Before Tax Ratio |
-0.36
|
0
|
0
|
0
|
-48.22
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$8.21 M
|
-$13.04 M
|
-$3.22 M
|
-$1.56 M
|
-$4.82 M
|
-$3.46 M
|
-$4.31 M
|
| Net Income Ratio |
-0.36
|
0
|
0
|
0
|
-48.22
|
0
|
0
|
| EPS |
-55.21 |
-6242.18 |
-165346 |
-815.8 |
-32856 |
-23606 |
-29385 |
| EPS Diluted |
-55.21 |
-6242.18 |
-165346 |
-815.8 |
-32856 |
-23606 |
-29385 |
| Weighted Average Shares Out |
$183.28 K
|
$44.18 K
|
$32.49 K
|
$324.87 K
|
$24.95 K
|
$24.95 K
|
$24.95 K
|
| Weighted Average Shares Out Diluted |
$183.28 K
|
$44.18 K
|
$32.49 K
|
$324.87 K
|
$24.95 K
|
$24.95 K
|
$24.95 K
|
| Link |
|
|
|
|
|
|
|
